A New Treatment for Prosthetic Infections?
Proteolytic enzymes: a new treatment strategy for prosthetic infections? by Selan L, Berlutti F, Passariello C, Comodi-Ballanti MR, Thaller MC Istituto di Microbiologia, Facolta di Farmacia, Universi |
A preliminary trial of serrapeptase in patients with carpal tunnel syndrome.
A preliminary trial of serrapeptase in patients with carpal tunnel syndrome. Panagariya A, Sharma AK Dept. of Neurology, SMS Medical College and Hospital, Jaipur. J Assoc Physicians India 1999 |
Development of Ketsumeisei
The development of the Ketsumeisei formula
Ketsumeisei, a liquid extract of several herbs, has been developed according to traditional Chinese medicine theory and is an adaptation of ea |
Ketsumeisei Case Studies
Case Studies
Ketsumeisei Treatment
Below are numerous case studies involving patients treated using the philosophy of blended Eastern & Western therapies. In the diabetes cases, or |
Management of Type II Diabetes: Chinese Herbal Therapy
Management of Type II Diabetes - Chinese Herbal Therapy
Symptomatic therapy is a microscopic approach at the molecular level, whereas lifestyle modifications and improvement of the constitut |
Serrapeptase: Acute or Chronic Inflammation of Otorhinolaryngology Pathology
Evaluation of Serratia Peptidase in Acute or Chronic Inflammation of Otorhinolaryngology Pathology: a Multicentre, Double-blind, Randomized Trial versus Placebo
A. Mazzone, M. Catalan, M |
Serrapeptase: Treatment of Breast Engorgement
The treatment of breast engorgement with Serrapeptase (Danzen): a randomised double-blind controlled trial. Kee WH, Tan SL, Lee V, Salmon YM. Singapore Med J 1989 Feb;30(1):48-54 We evaluated an anti |
Serrapeptase: Post-antrotomy Buccal Swelling
A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling. Tachibana M, Mizukoshi O, Harada Y, Kawamoto K, Nakai Y. Pharmatherapeutica 1984;3(8):526-30 A mul |
Type II Diabetes is a Liver Disease
Type II Diabetes is a Liver Disease
by Dr. Xianen Wang
Introduction
Diabetic Statistical Overview
Patients with type 2 diabetes mellitus account for 95% of those with d |
|
|
|
